These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 24269849

  • 41. Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial.
    Liew SH, Nichols KK, Klamerus KJ, Li JZ, Zhang M, Foulks GN.
    Ophthalmology; 2012 Jul; 119(7):1328-35. PubMed ID: 22525048
    [Abstract] [Full Text] [Related]

  • 42. Upregulation of the IL-33/ST2 pathway in dry eye.
    Wang S, Zhang H.
    Mol Vis; 2019 Jul; 25():583-592. PubMed ID: 31673224
    [Abstract] [Full Text] [Related]

  • 43. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E, Asfuroğlu E.
    Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
    [Abstract] [Full Text] [Related]

  • 44. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
    Narayanan S, Corrales RM, Farley W, McDermott AM, Pflugfelder SC.
    Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
    [Abstract] [Full Text] [Related]

  • 45. Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease.
    Tawfik A, Pistilli M, Maguire MG, Chen Y, Yu Y, Greiner JV, Asbell PA, Ying GS, Dry Eye Assessment and Management (DREAM) Study Research Group.
    Ophthalmic Epidemiol; 2024 Jun; 31(3):274-282. PubMed ID: 37592829
    [Abstract] [Full Text] [Related]

  • 46. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS, MacKenzie KR, Cook AE, Leatherbarrow B.
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [Abstract] [Full Text] [Related]

  • 47. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
    Yang S, Lee HJ, Kim DY, Shin S, Barabino S, Chung SH.
    Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
    [Abstract] [Full Text] [Related]

  • 48. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease.
    Denoyer A, Rabut G, Baudouin C.
    Ophthalmology; 2012 Sep; 119(9):1811-8. PubMed ID: 22591770
    [Abstract] [Full Text] [Related]

  • 49. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
    Khamar P, Nair AP, Shetty R, Vaidya T, Subramani M, Ponnalagu M, Dhamodaran K, D'souza S, Ghosh A, Pahuja N, Deshmukh R, Ahuja P, Sainani K, Nuijts RMMA, Das D, Ghosh A, Sethu S.
    Invest Ophthalmol Vis Sci; 2019 Jun 03; 60(7):2532-2542. PubMed ID: 31195410
    [Abstract] [Full Text] [Related]

  • 50. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC, Jeong IY, Park YG, Yang SY.
    Cornea; 2007 May 03; 26(4):431-7. PubMed ID: 17457192
    [Abstract] [Full Text] [Related]

  • 51. FTY720 ameliorates Dry Eye Disease in NOD mice: Involvement of leukocytes inhibition and goblet cells regeneration in ocular surface tissue.
    Xiao W, Xu GT, Zhang J, Zhang J, Zhang Y, Ye W.
    Exp Eye Res; 2015 Sep 03; 138():145-52. PubMed ID: 26187517
    [Abstract] [Full Text] [Related]

  • 52. Tear film osmolarity in ocular mucous membrane pemphigoid.
    Miserocchi E, Iuliano L, Berchicci L, Bandello F, Modorati G.
    Cornea; 2014 Jul 03; 33(7):668-72. PubMed ID: 24858022
    [Abstract] [Full Text] [Related]

  • 53. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
    Hongyok T, Chae JJ, Shin YJ, Na D, Li L, Chuck RS.
    Arch Ophthalmol; 2009 Apr 03; 127(4):525-32. PubMed ID: 19365035
    [Abstract] [Full Text] [Related]

  • 54. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K, Bunya V, Maguire M, Asbell P, Ying GS, Dry Eye Assessment and Management Study Research Group.
    Ophthalmology; 2021 Oct 03; 128(10):1384-1392. PubMed ID: 33785415
    [Abstract] [Full Text] [Related]

  • 55. Association Between Sleep Quality, Mood Status, and Ocular Surface Characteristics in Patients With Dry Eye Disease.
    Wu M, Liu X, Han J, Shao T, Wang Y.
    Cornea; 2019 Mar 03; 38(3):311-317. PubMed ID: 30614900
    [Abstract] [Full Text] [Related]

  • 56. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye.
    Julio G, Lluch S, Pujol P, Merindano MD.
    Ophthalmic Physiol Opt; 2012 Jul 03; 32(4):317-23. PubMed ID: 22620852
    [Abstract] [Full Text] [Related]

  • 57. Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.
    Chen Y, Zhang X, Yang L, Li M, Li B, Wang W, Sheng M.
    Mol Med Rep; 2014 May 03; 9(5):2015-23. PubMed ID: 24626526
    [Abstract] [Full Text] [Related]

  • 58. The features of dry eye disease in a Japanese elderly population.
    Uchino M, Dogru M, Yagi Y, Goto E, Tomita M, Kon T, Saiki M, Matsumoto Y, Uchino Y, Yokoi N, Kinoshita S, Tsubota K.
    Optom Vis Sci; 2006 Nov 03; 83(11):797-802. PubMed ID: 17106406
    [Abstract] [Full Text] [Related]

  • 59. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome.
    Jee D, Park M, Lee HJ, Kim MS, Kim EC.
    J Cataract Refract Surg; 2015 Apr 03; 41(4):756-63. PubMed ID: 25487027
    [Abstract] [Full Text] [Related]

  • 60. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease.
    Deinema LA, Vingrys AJ, Wong CY, Jackson DC, Chinnery HR, Downie LE.
    Ophthalmology; 2017 Jan 03; 124(1):43-52. PubMed ID: 27817918
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.